Empowered Funds’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.98M Buy
59,848
+46,391
+345% +$5.05M 0.05% 451
2026
Q1
$1.24M Sell
13,457
-58,422
-81% -$5.87M 0.01% 1324
2025
Q4
$7.34M Buy
71,879
+65,012
+947% +$5.82M 0.12% 189
2025
Q3
$429K Buy
6,867
+772
+13% +$42K ﹤0.01% 1459
2025
Q2
$317K Sell
6,095
-341
-5% -$15.2K ﹤0.01% 1478
2025
Q1
$274K Buy
+6,436
New +$278K ﹤0.01% 1434

Other funds holding GH

Empowered Funds's GH Position: Q2 2026 in Review

Empowered Funds increased its Guardant Health (GH) stake by 345% in Q2 2026, buying an estimated $5.05M and bringing the position to 59,848 shares worth $8.98M. The position accounts for 0.05% of the portfolio, ranked #451.

Empowered Funds first reported a position in GH in Q1 2025 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Empowered Funds held 59,848 shares of Guardant Health worth $8.98M as of Q2 2026.
  • Empowered Funds bought 46,391 Guardant Health shares in Q2 2026, an estimated $5.05M.
  • Guardant Health made up 0.05% of Empowered Funds's portfolio in Q2 2026, its #451 holding.
  • Empowered Funds first reported a position in Guardant Health in Q1 2025 and has held it in 6 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.